United States Wearable Neurorehabilitation Devices Market Size, Share, and COVID-19 Impact Analysis, By Application (Stroke, Spinal Cord Injury, Cerebral Palsy, and Others), By End-user (Hospitals/Clinics, Rehabilitation Centers, and Others), and United States Wearable Neurorehabilitation Devices Market Insights, Industry Trend, Forecasts to 2035.

Industry: Healthcare

RELEASE DATE Jun 2025
REPORT ID SI11555
PAGES 190
REPORT FORMAT PathSoft

United States Wearable Neurorehabilitation Devices Market Insights Forecasts to 2035

  • The USA Wearable Neurorehabilitation Devices Market Size is Expected to Grow at a CAGR of around 10.7% from 2025 to 2035.
  • The U.S. Wearable Neurorehabilitation Devices Market Size is Expected to Hold a Significant Share by 2035.

 

United States Wearable Neurorehabilitation Devices Market

Get more details on this report -

Request Free Sample PDF

According to a research report published by Spherical Insights & Consulting, The U.S. Wearable Neurorehabilitation Devices Market is Expected to hold a significant share By 2035, Growing at a CAGR of 10.7% from 2025 to 2035.  The U.S. wearable neurorehabilitation devices market is growing due to rising neurological disorders like stroke and spinal injuries. Advances in wearable tech, AI integration, and remote rehabilitation boost adoption. Supportive government initiatives and favourable reimbursements also drive growth, despite challenges like high costs and regulatory hurdles, presenting promising opportunities for market expansion.

 

Market Overview

The United States wearable neurorehabilitation devices market refers to the sector focused on the development, manufacturing, and distribution of wearable technologies designed to assist patients with neurological disorders in their rehabilitation process. The market is experiencing significant growth, driven by the increasing prevalence of neurological disorders such as stroke, spinal cord injuries, and cerebral palsy. Advancements in wearable technology, including improved sensors and real-time monitoring capabilities, enhance patient outcomes and therapy personalization. The market’s strengths include advanced AI and real-time monitoring, strong healthcare infrastructure, growing patient awareness, and collaborations between tech firms and healthcare providers that boost innovation, along with government support and escalating demand for personalized rehabilitation, driving market growth and adoption. The market offers opportunities in expanding home-based rehabilitation, integrating AI for personalized therapy, and developing cost-effective solutions. The growing elderly population and increasing investments in neurotechnology further boost the potential for innovation and market penetration. Moreover, supportive government initiatives and favourable reimbursement policies are facilitating broader adoption of these technologies.

 

Report Coverage

This research report categorizes the market for the United States wearable neurorehabilitation devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the U.S. wearable neurorehabilitation devices market. Recent market developments and competitive strategies such as expansion, product launch, development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the USA wearable neurorehabilitation devices market.

 

United States Wearable Neurorehabilitation Devices Market Report Coverage

Report CoverageDetails
Base Year:2024
Forecast Period:2025-2035
Forecast Period CAGR 2025-2035 :10.7%
Historical Data for:2020-2023
No. of Pages:190
Tables, Charts & Figures:98
Segments covered:By Application, By End-user and COVID-19 Impact Analysis
Companies covered:: Emotiv Inc., NeuroSky Inc., Empatica Inc., Zynex Inc., Cadence Biomedical, Flint Rehabilitation Devices, Ekso Bionics Holdings, Inc., Myomo Inc., Bioness Inc., Neuro Rehab VR, MedRhythms, AlterG, Inc., ReWalk Robotics Ltd., Neofect USA, Kinova Robotics, and other key vendors.
Pitfalls & Challenges:COVID-19 Empact, Challenge, Future, Growth, & Analysis

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The growing prevalence of neurological disorders such as stroke, spinal cord injuries, and cerebral palsy, increasing the demand for effective rehabilitation solutions. Advances in wearable technology, including improved sensors, AI integration, and real-time monitoring, enhance patient outcomes and therapy personalization. Rising healthcare expenditure and growing awareness among clinicians and patients about the benefits of wearable neurorehabilitation devices further boost market growth. Growing co-operation between technology developers and healthcare providers also accelerates innovation and accessibility. Furthermore, supportive government initiatives and funding for neurorehabilitation research provide opportunities for market expansion and improved patient care.

 

Restraining Factors

The high device costs, limited reimbursement policies, and lack of awareness among patients and healthcare providers collectively slow market growth despite rising demand for advanced rehabilitation solutions. Additionally, technical challenges like device complexity and integration issues, along with data privacy concerns, hinder widespread adoption.

 

Market Segmentation

The United States wearable neurorehabilitation devices market share is classified into application and end-user.

 

  • The stroke segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United States wearable neurorehabilitation devices market is segmented by application into stroke, spinal cord injury, cerebral palsy, and others. Among these, the stroke segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to the high prevalence of stroke survivors requiring extensive rehabilitation. Wearable devices aid in improving motor function, balance, and recovery outcomes, making them essential tools for stroke therapy. This drives significant demand and market share in this segment.

 

  • The hospitals/clinics segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United States wearable neurorehabilitation devices market is segmented by end-user into hospitals/clinics, rehabilitation centers, and others. Among these, the hospitals/clinics segment held a substantial share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is attributed to their advanced infrastructure, skilled medical professionals, and higher patient influx. These facilities offer comprehensive rehabilitation services, making them primary adopters of wearable technologies for effective diagnosis, therapy, and continuous patient monitoring, driving significant market share.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United States wearable neurorehabilitation devices market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Emotiv Inc.
  • NeuroSky Inc.
  • Empatica Inc.
  • Zynex Inc.
  • Cadence Biomedical
  • Flint Rehabilitation Devices
  • Ekso Bionics Holdings, Inc.
  • Myomo Inc.
  • Bioness Inc.
  • Neuro Rehab VR
  • MedRhythms
  • AlterG, Inc.
  • ReWalk Robotics Ltd.
  • Neofect USA
  • Kinova Robotics
  • Others

 

Recent Developments:

  • In January 2024, Ekso Bionics launched GaitCoach, a next-generation gait therapy software for its EksoNR exoskeleton. Designed to enhance patient rehabilitation, GaitCoach offers real-time feedback and personalized guidance, aiming to improve user trust and simplify robotic therapy. Initial user feedback indicates high satisfaction, with 96% finding the software intuitive and 93% valuing its guidance.

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting and Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at the U.S., regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United States wearable neurorehabilitation devices market based on the below-mentioned segments

 

USA Wearable Neurorehabilitation Devices Market, By Application

  • Stroke
  • Spinal Cord Injury
  • Cerebral Palsy
  • Others

 

USA Wearable Neurorehabilitation Devices Market, By End-user

  • Hospitals/Clinics
  • Rehabilitation Centers
  • Others

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies